Bayesian Stacking of Quantitative Adverse Outcome Pathways Isolates Primary Drivers of Liver Steatosis

Authors

Steinbach, A. M., Marx-Stoelting, P., Willenbockel, C. T.

Abstract

The quantification of adverse outcome pathways (qAOPs) involving multiple converging pathways remains a fundamental challenge in toxicology. This difficulty is worsened by small in vitro datasets with missing values and heteroscedasticity, which limit the estimation of non-linear response functions and the robust estimation of uncertainty. To overcome these limitations, we developed a framework for estimating a Bayesian qAOP Ensemble (Bayesian qAOPE) that combines heteroscedastic dose-response functions with continuous splines and linear models. By combining multiple converging non-linear pathways through Bayesian stacking, the most meaningful pathways are identified, and strongly correlated responses are naturally accounted for. Applying our approach to a hepatic steatosis dataset, we demonstrate by exact Bayesian leave-one-out cross-validation that our framework yields an exceptional predictive performance suitable for the derivation of a probabilistically weighted Benchmark Dose (BMD). Our framework is highly adaptable and provides a chemical-agnostic, mathematically founded blueprint for integrating multiple converging pathways in a Bayesian network.

Preprint server: bioRxiv
The authors list and abstract were imported from bioRxiv on 26 Oct 2026.

Stats

1-terrible, 9-excellent. How would you rate this preprint? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.